Health and Healthcare
AbbVie Little Changed Despite Big Bottom-Line Beat
Published:
Last Updated:
AbbVie Inc. (NYSE: ABBV) released its third-quarter financial results before the markets opened on Friday. The pharma giant said it posted $2.14 in earnings per share (EPS) and $8.24 billion in revenue, compared with consensus estimates that called for $2.02 in EPS and $8.23 billion in revenue. The same period from last year the North Chicago, Illinois-based company reported $1.41 in EPS and $7.0 billion in revenue.
AbbVie’s board of directors declared an increase in the company’s quarterly cash dividend from $0.96 per share to $1.07 per share, beginning with the dividend payable on Feb. 15, 2019, to shareholders of record as of Jan. 15, 2019.
In terms of its segments, AbbVie reported:
Looking ahead to the full year, the company expects to see EPS in the range of $7.90 to $7.92. Consensus estimates are calling for $7.88 in EPS and $32.89 billion in revenue for the 2018 full year.
Richard A. Gonzalez, chairman and chief executive officer of AbbVie, commented:
We delivered another exceptional quarter, with results well ahead of our expectations, including operational revenue growth above 18 percent and EPS growth greater than 50 percent. Based on our continued momentum across multiple products in our portfolio, we are raising our full year 2018 EPS guidance once again. We’re particularly pleased with our progress in building a leading hematologic oncology franchise, which is now delivering revenue in excess of $1 billion per quarter and is poised for continued strong growth next year and beyond.
Shares of AbbVie were up less than 1% to $81.00, as of 10:20 a.m., with a consensus analyst price target of $105.79 and a 52-week range of $77.50 to $125.86.
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.